SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

05 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 6276.30 millions, up 19.63% as compared to Rs. 5246.30 millions during the corresponding quarter last year.The Company has registered profit of Rs. 866.20  millions for the quarter ended March 2025, a growth of 12.99%  over Rs. 766.60 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended March 2025 rose to 1767.80 millions as compared to 1569.10 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 6276.30 5246.30 19.63 25501.30 19291.90 32.19 25501.30 19291.90 32.19
Other Income 34.00 15.20 123.68 152.10 65.20 133.28 152.10 65.20 133.28
PBIDT 1767.80 1569.10 12.66 7259.30 4877.20 48.84 7259.30 4877.20 48.84
Interest 117.70 136.90 -14.02 532.70 734.90 -27.51 532.70 734.90 -27.51
PBDT 1650.10 1432.20 15.21 6726.60 4142.30 62.39 6726.60 4142.30 62.39
Depreciation 339.50 303.80 11.75 1325.60 1235.60 7.28 1325.60 1235.60 7.28
PBT 1310.60 1128.40 16.15 5401.00 2906.70 85.81 5401.00 2906.70 85.81
TAX 444.40 361.80 22.83 1834.00 948.80 93.30 1834.00 948.80 93.30
Deferred Tax 294.00 162.40 81.03 852.30 421.70 102.11 852.30 421.70 102.11
PAT 866.20 766.60 12.99 3567.00 1957.90 82.18 3567.00 1957.90 82.18
Equity 431.40 415.50 3.83 431.40 415.50 3.83 431.40 415.50 3.83
PBIDTM(%) 28.17 29.91 -5.83 28.47 25.28 12.60 28.47 25.28 12.60

Epigral Share Price

1097.65 34.00 (3.20%)
12-Jun-2026 11:43 View Price Chart
Peers
Company Name CMP
SRF 2705.00
BASF India 3305.60
Tata Chemicals 747.40
Pidilite Inds. 1545.40
Deepak Nitrite 1669.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: